The committee will vote Thursday whether FDA should let Pfizer’s COVID-19 vaccine be the first allowed in the U.S. Most vaccines never get that far.
Author: Elizabeth Weise, USA TODAY
CDC-convened panel votes to add nursing home residents to first phase of COVID-19 vaccine rollout
Front-line health care workers are clearly first in line for a COVID-19 vaccine. Then there’s the question of who else should be in the initial group.
When could the first COVID-19 vaccines be given in the US?
Given the regulatory timeline, Dec. 13 is the earliest the first round of vaccine against the coronavirus could start to be given to select Americans.
COVID-19 vaccines are almost ready to be distributed. Who gets them after health care workers? Here’s a list.
When a COVID-19 vaccine is ready , people who risk their lives to care for the sick will be first in line to get one. Here’s a list of who’s next.
Thanksgiving would be the earliest a COVID-19 vaccine could arrive, Pfizer says
An open letter from the frontrunner COVID-19 vaccine producer published Friday ends any expectations a vaccine might be available before Election Day.
Herd immunity strategy endorsed by White House a ‘ridiculous’ way to stop COVID, say scientists — it will just kill people
Herd immunity, the idea that if enough people get a disease it will stop spreading, won’t work for COVID-19, say scientists. Trump thinks it could.
A COVID-19 vaccine by Election Day? Here are the 3 things that would need to happen, and soon.
Could an approved coronavirus vaccine be released before Election Day on Nov. 3? It’s extremely unlikely but not impossible, experts say.
Federal government wants COVID vaccine distribution system in place and ready to roll by Nov. 1
To prepare for deadline, test runs will start next month on logistics to distribute millions of doses of vaccine in the US, says UPS official
Texas-based McKesson tapped to help get coronavirus vaccines into American communities
The U.S. government has chosen medical supplier McKesson to be a centralized distributor for future coronavirus vaccines.
Biggest coronavirus vaccine deal yet: $2.1 billion to Sanofi/GSK for up to 100 million doses
The United States will pay Sanofi and GlaxoSmithKline up to $2.1 billion to test and produce 100 million doses of an experimental coronavirus vaccine.